These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 29068826)

  • 1. Opioid Addiction in Pregnancy: Does Depression Negatively Impact Adherence With Prenatal Care?
    Hensley L; Sulo S; Kozmic S; Parilla BV
    J Addict Med; 2018; 12(1):61-64. PubMed ID: 29068826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of naltrexone in treating opioid use disorder in pregnancy.
    Towers CV; Katz E; Weitz B; Visconti K
    Am J Obstet Gynecol; 2020 Jan; 222(1):83.e1-83.e8. PubMed ID: 31376396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled trials in pregnancy: scientific and ethical aspects. Exposure to different opioid medications during pregnancy in an intra-individual comparison.
    Unger A; Jagsch R; Jones H; Arria A; Leitich H; Rohrmeister K; Aschauer C; Winklbaur B; Bäwert A; Fischer G
    Addiction; 2011 Jul; 106(7):1355-62. PubMed ID: 21438938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed Neonates.
    Kelty E; Hulse G
    Drugs; 2017 Jul; 77(11):1211-1219. PubMed ID: 28536981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway.
    Nechanská B; Mravčík V; Skurtveit S; Lund IO; Gabrhelík R; Engeland A; Handal M
    Addiction; 2018 Jul; 113(7):1286-1294. PubMed ID: 29443414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.
    Winhusen T; Wilder C; Wexelblatt SL; Theobald J; Hall ES; Lewis D; Van Hook J; Marcotte M
    Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Could prenatal food insecurity influence neonatal abstinence syndrome severity?
    Rose-Jacobs R; Trevino-Talbot M; Lloyd-Travaglini C; Cabral HJ; Vibbert M; Saia K; Wachman EM
    Addiction; 2019 Feb; 114(2):337-343. PubMed ID: 30422365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.
    Kakko J; Heilig M; Sarman I
    Drug Alcohol Depend; 2008 Jul; 96(1-2):69-78. PubMed ID: 18355989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antenatal methadone vs buprenorphine exposure and length of hospital stay in infants admitted to the intensive care unit with neonatal abstinence syndrome.
    Tolia VN; Murthy K; Bennett MM; Miller ES; Benjamin DK; Smith PB; Clark RH
    J Perinatol; 2018 Jan; 38(1):75-79. PubMed ID: 29048415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buprenorphine medication-assisted treatment during pregnancy: An exploratory factor analysis associated with adherence.
    Coker JL; Catlin D; Ray-Griffith S; Knight B; Stowe ZN
    Drug Alcohol Depend; 2018 Nov; 192():146-149. PubMed ID: 30253377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buprenorphine compared with methadone in opioid-dependent pregnant women: How does it affect neonatal abstinence syndrome?
    Bivin B; Waring A; Alves P
    J Am Assoc Nurse Pract; 2019 Dec; 33(2):119-125. PubMed ID: 31809398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid dependency in pregnancy and length of stay for neonatal abstinence syndrome.
    Pritham UA; Paul JA; Hayes MJ
    J Obstet Gynecol Neonatal Nurs; 2012 Mar; 41(2):180-190. PubMed ID: 22375882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy.
    O'Connor AB; Collett A; Alto WA; O'Brien LM
    J Midwifery Womens Health; 2013; 58(4):383-8. PubMed ID: 23931660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome. A national prospective study.
    Bakstad B; Sarfi M; Welle-Strand GK; Ravndal E
    Eur Addict Res; 2009; 15(3):128-34. PubMed ID: 19332991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal buprenorphine versus methadone exposure and neonatal outcomes: systematic review and meta-analysis.
    Brogly SB; Saia KA; Walley AY; Du HM; Sebastiani P
    Am J Epidemiol; 2014 Oct; 180(7):673-86. PubMed ID: 25150272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infants Born to Opioid-Dependent Women in Ontario, 2002-2014.
    Brogly SB; Turner S; Lajkosz K; Davies G; Newman A; Johnson A; Dow K
    J Obstet Gynaecol Can; 2017 Mar; 39(3):157-165. PubMed ID: 28343557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal abstinence syndrome after methadone or buprenorphine exposure.
    Jones HE; Kaltenbach K; Heil SH; Stine SM; Coyle MG; Arria AM; O'Grady KE; Selby P; Martin PR; Fischer G
    N Engl J Med; 2010 Dec; 363(24):2320-31. PubMed ID: 21142534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are there gender related differences in neonatal abstinence syndrome following exposure to buprenorphine during pregnancy?
    O'Connor AB; O'Brien L; Alto WA
    J Perinat Med; 2013 Sep; 41(5):621-3. PubMed ID: 23612625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of prenatal alcohol co-exposure on neonatal abstinence syndrome in infants born to mothers in opioid maintenance treatment.
    Kreitinger C; Gutierrez H; Hamidovic A; Schmitt C; Sarangarm P; Rayburn WF; Leeman L; Bakhireva LN
    J Matern Fetal Neonatal Med; 2016 Mar; 29(5):783-8. PubMed ID: 25758627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009.
    Welle-Strand GK; Skurtveit S; Jones HE; Waal H; Bakstad B; Bjarkø L; Ravndal E
    Drug Alcohol Depend; 2013 Jan; 127(1-3):200-6. PubMed ID: 22841456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.